Chimerix (CMRX) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free CMRX Stock Alerts $0.90 +0.01 (+1.12%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineChimerix (CMRX) Set to Announce Quarterly Earnings on Wednesdaymarketbeat.com - April 25 at 11:47 AMChimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024globenewswire.com - April 24 at 7:00 AMChimerix (NASDAQ:CMRX) Shares Pass Below 200-Day Moving Average of $1.00americanbankingnews.com - April 24 at 4:06 AMChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 16 at 4:05 PMWe Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefullyfinance.yahoo.com - April 15 at 9:36 AMCMRX Apr 2024 1.000 putfinance.yahoo.com - March 16 at 2:02 PMCMRX Apr 2024 2.000 callfinance.yahoo.com - March 16 at 2:02 PMChimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 5 at 1:36 PMChimerix, Inc. (CMRX) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 2 at 1:58 AMChimerix: Tackling A Strong Unmet Need With Promising Dataseekingalpha.com - March 1 at 8:58 PMChimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 1 at 9:44 AMChimerix (NASDAQ:CMRX) Earns "Buy" Rating from HC Wainwrightmarketbeat.com - March 1 at 8:33 AMBuy Rating Affirmed for Chimerix Amid Progress in Dordaviprone’s Phase III Study and Strong Financial Outlookmarkets.businessinsider.com - February 29 at 7:19 PMChimerix, Inc.: Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Updatefinanznachrichten.de - February 29 at 9:18 AMChimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Resultsfinance.yahoo.com - February 29 at 9:18 AMChimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Updateglobenewswire.com - February 29 at 7:00 AMPreview: Chimerix's Earningsbenzinga.com - February 28 at 2:55 PMChimerix is about to announce its earnings — here's what Wall Street expectsmarkets.businessinsider.com - February 28 at 9:54 AMChimerix to Present at TD Cowen 44th Annual Health Care Conferencefinance.yahoo.com - February 27 at 8:12 AMChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024finance.yahoo.com - February 22 at 8:30 AMChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024globenewswire.com - February 22 at 7:00 AMChimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutionsfinance.yahoo.com - February 18 at 9:28 AMChimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99marketbeat.com - February 8 at 5:21 AMLightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)msn.com - January 9 at 1:03 PMChimerix Appoints Lisa Decker to Board of Directorsfinance.yahoo.com - December 29 at 8:59 AMPositive Signs As Multiple Insiders Buy Chimerix Stockfinance.yahoo.com - December 14 at 8:36 AMChimerix Names Michelle LaSpaluto to Chief Financial Officermarketwatch.com - December 4 at 9:37 AMChimerix promotes Michelle Laspaluto to CFOmsn.com - December 4 at 9:37 AMChimerix Appoints Michelle LaSpaluto As CFOmarkets.businessinsider.com - December 4 at 9:37 AMChimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - November 24 at 10:09 AMChimerix names Thomas Riga as Chief Operating and Commercial Officermsn.com - November 16 at 9:38 AMChimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officerfinance.yahoo.com - November 16 at 9:38 AMChimerix (NASDAQ:CMRX) shareholders have endured a 70% loss from investing in the stock five years agofinance.yahoo.com - November 3 at 9:45 AMChimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 3 at 9:45 AMChimerix Inc (CMRX) Reports Q3 2023 Financial Results and Operational Updatesfinance.yahoo.com - November 2 at 12:42 PMChimerix GAAP EPS of -$0.27 misses by $0.04, revenue of $0.01M misses by $0.08Mmsn.com - November 2 at 7:41 AMChimerix Reports Third Quarter 2023 Financial Results and Provides Operational Updatefinance.yahoo.com - November 2 at 7:41 AMChimerix Inc CMRXmorningstar.com - November 2 at 1:50 AMEarnings Outlook For Chimerixbenzinga.com - November 1 at 8:50 PMPeak 25: Mike Andriole – CEO of Chimerixbizjournals.com - October 26 at 10:18 PMChimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023finance.yahoo.com - October 26 at 7:17 AMChimerix, Inc. (CMRX)finance.yahoo.com - October 16 at 11:13 PMChimerix: Dangerous Road, Thesis Intactmsn.com - September 8 at 7:44 AMJonesTrading Sticks to Their Buy Rating for Chimerix (CMRX)markets.businessinsider.com - August 18 at 5:44 PMWedbush Reiterates Chimerix (CMRX) Outperform Recommendationmsn.com - August 17 at 10:33 PM4 Analysts Have This to Say About Chimerixmarkets.businessinsider.com - August 17 at 5:33 PMH.C. Wainwright Remains a Buy on Chimerix (CMRX)markets.businessinsider.com - August 16 at 5:36 PMChimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"finance.yahoo.com - August 16 at 5:36 PM5 Best Quality Penny Stocks to Buyinsidermonkey.com - August 13 at 4:00 PMCMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.investorplace.com - August 11 at 8:04 AM Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. CMRX Media Mentions By Week CMRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRX News Sentiment▼-0.100.33▲Average Medical News Sentiment CMRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRX Articles This Week▼41▲CMRX Articles Average Week Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BioXcel Therapeutics News Today Eton Pharmaceuticals News Today PMV Pharmaceuticals News Today Oncolytics Biotech News Today Affimed News Today Hookipa Pharma News Today YS Biopharma News Today Spero Therapeutics News Today Clearside Biomedical News Today Aclaris Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
